(NASDAQ:PRFX), TEL AVIV, Israel, Nov. 05, 2025 (GLOBE NEWSWIRE) — PainReform Ltd. (Nasdaq: PRFX), today announced that DeepSolar, its solar energy business unit developing next-generation AI-driven solar analytics, was recently featured in a Watchlist Interview produced in collaboration with The Market Link, highlighting its participation in the NVIDIA Connect program. The interview features key elements […]

(NASDAQ:JUNS), Jupiter, Florida, Nov. 05, 2025 (GLOBE NEWSWIRE) — Jupiter Neurosciences, Inc. (NASDAQ:JUNS), a clinical-stage pharmaceutical company developing JOTROL(TM), a patented resveratrol-based therapeutic platform targeting neuroinflammation and mitochondrial dysfunction, today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application to initiate a Phase 2a clinical trial of

(NASDAQ:TRUG), Introducing TruGolf Range, A Game-Changing Leap in the Future of Golf Practice SALT LAKE CITY, UT, Nov. 05, 2025 (GLOBE NEWSWIRE) — TruGolf Holdings Inc. (NASDAQ: TRUG) today announced what could become the most transformative innovation in modern golf practice: TruGolf Range – a next-generation indoor range platform that combines breathtaking realism, intelligent data,

(NasdaqGM:VWAV),(NasdaqGM:VWAVW), WEST HOLLYWOOD, Calif., Nov. 05, 2025 (GLOBE NEWSWIRE) — VisionWave Holdings, Inc. (Nasdaq: VWAV) (“VisionWave” or the “Company”) today announced that it has formally submitted complaints to Nasdaq MarketWatch and FINRA Market Regulation regarding apparent abnormal and potentially manipulative trading activity in the Company's common stock observed on November 3-4, 2025. The Company provided

(Other OTC:TRWD),(OTC US:TRWD), NEW YORK, Nov. 05, 2025 (GLOBE NEWSWIRE) — Tradewinds Universal, Inc. (OTC: TRWD), a publicly traded holding company expanding within the entertainment sector, announced today the launch of a global media campaign designed to increase shareholder value, brand visibility and public recognition across North America, Latin America, and select international markets. The

(TSX-V:ARCH),(OTC US:ACHFF),(Other OTC:ACHFF), TORONTO, Nov. 05, 2025 (GLOBE NEWSWIRE) — Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) announced today that the Fraser Health Research Ethics Board (“REB”) has granted approval for the Royal Columbian Hospital (RCH) to participate in Arch's ongoing Phase II trial evaluating LSALT peptide for the

(NASDAQ:NXL),(NASDAQ:NXLIW), HOUSTON, TX, Nov. 05, 2025 (GLOBE NEWSWIRE) — Nexalin Technology, Inc. (Nasdaq: NXL) (the “Company” or “Nexalin”), the leader in Deep Intracranial Frequency Stimulation (DIFS(TM)) of the brain, today announced that the U.S. Food and Drug Administration (“FDA”) has formally accepted its Q-Submission (“Q-Sub”) related to the Company's Gen-2 Console (“SYNC”) system for the

Phase 1a/1b study will evaluate NRM-823 as monotherapy and in combination with immune checkpoint inhibition in patients with locally-advanced or metastatic refractory solid tumors NRM-823 is a T cell engager against an immuno-active novel target that is homogeneously and commonly expressed in a broad range of solid tumors BOSTON and NEW HAVEN, Conn., Nov. 05,

(NasdaqGM:YDES), Taipei, Taiwan, Nov. 05, 2025 (GLOBE NEWSWIRE) — YD Bio Limited (“YD Bio” or the “Company”) (NasdaqGM: YDES), a biotechnology company advancing DNA methylation-based cancer detection technology and ophthalmologic innovations, today announced its support for the global commercialization of OkaiDx(TM), a researchâ€'useâ€'only (RUO) blood test for postâ€'treatment breast cancer monitoring now available through the

CALGARY, Alberta, Nov. 05, 2025 (GLOBE NEWSWIRE) — With Canada's affordable housing crisis at a breaking point, a national foundation, dedicated solely to affordable housing, is transforming the way Canada invests in affordable housing. Partners for Affordable Housing is mobilizing socially inspired capital – the blend of philanthropy, corporate community investment, and social impact financing